The University of Michigan School of Medicine recently jumped on the no-pharma-funding bandwagon: It will stop accepting commercial support of CME on January 1, 2011. According to a statement by the dean of the medical school and associate dean of regulatory affairs, “The decision was based on a review of literature about the influence on clinical faculty of industry-funded CME.” The Sloan Kettering Memorial Cancer Center in New York and Kaiser Permanente’s mid-Atlantic region also have ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to University of Michigan Bans Commercial Support, you'll get exclusive access to a large archive of premium content.

Already registered? here.